Member Events

With over 76 hours of networking opportunities and 12 social events, CAP19 is an opportunity make connections that matter. Advance your career and practice by interacting with the most respected leaders in pathology.

Scientific Plenary

The Patient Microbiome

James Versalovic, MD, PhD, FCAP
Colleen S. Kraft, MD, MS
Christoph A. Thaiss, PhD

Sunday, September 22

This year’s scientific plenary discussion focuses on the microbiome and its relevance to future patient therapies. Attending this event will instill an understanding about this emerging science, its relevancy to everyday practice, and the impact on pathology and laboratory medicine. Facilitated by CAP member James Versalovic, MD, PhD, FCAP, our scientific plenary panel is comprised of pioneering microbiologists and researchers.

Keynote Speaker​

AI: How Data Will Be Integrated to Serve Patients

Jamie Heywood

Sunday, September 22

Join us to hear fresh perspectives from keynote speaker Jamie Heywood—an innovator driving the application of artificial intelligence and digital biology to understand health, disease, and aging—a future of truly personalized medicine.

As chairman of PatientsLikeMe, Heywood provides the scientific vision and architecture for its patient-centered medical platform. Named one of “15 companies that will change the world” by CNN Money, PatientsLikeMe is a personalized research and peer care platform that allows patients to share in-depth information on treatments, symptoms, and outcomes. This novel open model allows clinicians, providers, and the pharmaceutical industry to better understand diseases and the patient experience. Patients improve their care while actively partnering with industry to accelerate and influence the development of new treatments and biomarkers.

Heywood’s work has been the subject of His Brother’s Keeper, a book by Pulitzer Prize-winning author Jonathan Weiner, and So Much So Fast, a Sundance award-winning documentary. Heywood co-founded his company in 2004 with his brother, Benjamin, and friend, Jeff Cole.

Special Lecture​

The Evolution of Molecular Diagnostics: From the Southern Blot to Extreme PCR

Carl T. Wittwer, MD, PhD, FCAP

Tuesday, September 24

The entrepreneurial chant of, “faster, cheaper, better” continues to guide the future of molecular diagnostics. Join us as Carl T. Wittwer, MD, PhD, FCAP plots the evolution of molecular diagnostics from his viewpoint as a contributor and user of molecular technology. The development of rapid-cycle PCR technology, HRM, extreme PCR, high-speed melting, and syndromic testing all focus on increasing the utility and speed of molecular analysis. Dr. Wittwer’s efforts cross boundaries that separate academia and industry – as professor of pathology at the University of Utah, medical director at ARUP Laboratories, and founder and chairman in various private industry entities. With over 200 publications, 40 US patents, and their foreign equivalents, he currently serves as an associate editor of Clinical Chemistry and a senior editor of the Tietz Textbook of Clinical Chemistry and Molecular Diagnostics.